December 8, 2021

Milne News

News Reported Raw, Real and Truthfully

Reports That Trump Will Benefit Financially From Hydroxychloroquine Is Fake News

3 min read
Reports That Trump Will Benefit Financially From Hydroxychloroquine Is Fake News

The New York Times published a story so fake that even Snopes was forced to debunk it.

On Tuesday, along with three other so-called “journalists,” Maggie Haberman published a story that questioned President Trump’s motives for touting, an anti-malaria that is perfectly safe (in consultation with a doctor). Although the formal studies have not yet been completed, there is plenty of anecdotal and medical evidence that hydroxychloroquine does help coronavirus sufferers.

It’s clear to see that because it is President Trump touting hydroxychloroquine the far-left is trying in any way to discredit the drug in order to discredit Trump. and this is exactly what the New York Times accomplished… Maggie Haberman and her co-conspirators deliberately and falsely suggested President Trump has a financial motive:

Another investor in both Sanofi and Mylan, another pharmaceutical firm, is Invesco, the fund previously run by Wilbur Ross, the commerce secretary. Mr. Ross said in a statement Monday that he “was not aware that Invesco has any investments in companies producing” the drug, “nor do I have any involvement in the decision to explore this as a treatment.”

As of last year, Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.

The audacious and intentional lies here are of omission, and those lies of omission are so audacious even the left-wing Snopes was moved to clear the air. Although Snopes did not have the moral courage to actually target the New York Times directly as the source of this hoax most likely due to the fact that just about every media outlet ran with the fake news story as well, it did label the idea Trump will benefit financially from hydroxychloroquine as “mostly false“:

Trump’s financial stake in these companies is virtually negligible — contained indirectly via mutual funds — and administered through three family trusts he does not control. As a generic drug, hydroxychloroquine is unlikely to provide any one company with significant profits compared to other proprietary drugs.

The problem here is that Snopes is being somewhat dishonest. This is not a “mostly false” case. The New York Times story is without question “false.” And the word “negligible” doesn’t begin to describe something worth less than $500 to a man worth billions.

This piece from Haberman and her co-conspirators is nothing short of an outrageous and desperate hit piece and is riddled with fake news — but hey, what do you expect from the New York Times.

Help Milne News stay online and continue our great work in bringing you the News Reported Raw, Real and Truthfully…No BS…Any donation is greatly appreciated:

Thank you for your support.

Or Via Stripe:  any kind of credit or debit card:  Visa, MasterCard, American Express, JCB, Discover, and Diners Club. (NO SIGN UP REQUIRED)

Get the latest news delivered straight to your inbox for free every day by signing up below.


Leave a Reply